CIK 0001490978 · Large accelerated filer
Schrodinger, Inc.
Sign in to watch- Ticker
- SDGR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 954284541
- Phone
- 503-299-1150
- Business address
- 1540 BROADWAY, 24TH FLOOR, NEW YORK, NY, 10036
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,781,663
- in 3 filings, $2.8M under 10b5-1 plans
Net −$2,781,663. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-04-17 | Farid Ramy President & CEO | Option exercise · Stock Option (right to buy) 10b5-1 | −43,000 | 74,527 | ||
| 2026-04-17 | Farid Ramy President & CEO | Option exercise · Stock Option (right to buy) 10b5-1 | −74,527 | 0 | ||
| 2026-04-16 | Jain Rachit EVP & CFO | Sale 10b5-1 | −844 | $12.75 | $11K | 51,752 |
| 2026-04-16 | Farid Ramy President & CEO | Option exercise 10b5-1 | +43,000 | $3.07 | $132K | 373,824 |
| 2026-04-16 | Farid Ramy President & CEO | Sale 10b5-1 | −43,000 | $12.33 | $530K | 330,824 |
| 2026-04-16 | Farid Ramy President & CEO | Option exercise · Stock Option (right to buy) 10b5-1 | −43,000 | 117,527 | ||
| 2026-03-06 | Herman Jenny CAO | Sale 10b5-1 | −608 | $12.84 | $8K | 34,804 |
| 2026-03-05 | Jain Rachit EVP & CFO | Sale 10b5-1 | −1,631 | $12.90 | $21K | 52,596 |
| 2026-03-05 | Herman Jenny CAO | Sale 10b5-1 | −775 | $12.85 | $10K | 35,412 |
| 2026-03-05 | Tran Yvonne EVP, CLO & CPO | Sale 10b5-1 | −1,094 | $12.90 | $14K | 52,683 |
| 2026-03-05 | Lorton Kenneth Patrick EVP, CTO & COO, Software | Sale 10b5-1 | −1,222 | $12.90 | $16K | 89,241 |
| 2026-03-05 | Farid Ramy President & CEO | Sale 10b5-1 | −3,661 | $12.91 | $47K | 330,824 |
| 2026-03-05 | Akinsanya Karen See Remarks | Sale 10b5-1 | −1,366 | $12.90 | $18K | 69,956 |
| 2026-03-04 | Abel Robert Lorne See Remarks | Sale 10b5-1 | −1,300 | $12.81 | $17K | 55,897 |
| 2026-03-02 | Jain Rachit EVP & CFO | Grant or award | +17,130 | 54,227 | ||
| 2026-03-02 | Jain Rachit EVP & CFO | Grant or award · Stock Option (right to buy) | +34,250 | 34,250 | ||
| 2026-03-02 | Aklian Mannix Vartan See Remarks | Grant or award | +17,130 | 31,193 | ||
| 2026-03-02 | Aklian Mannix Vartan See Remarks | Grant or award · Stock Option (right to buy) | +34,250 | 34,250 | ||
| 2026-03-02 | Friesner Richard Director | Option exercise | +160,527 | $3.07 | $493K | 682,224 |
| 2026-03-02 | Friesner Richard Director | Option exercise · Stock Option (right to buy) | −160,527 | 0 |
Page 3 of 11 · 214 trades